286 related articles for article (PubMed ID: 14665560)
21. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
[TBL] [Abstract][Full Text] [Related]
22. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D
J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096
[TBL] [Abstract][Full Text] [Related]
23. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
Rampe D; Murawsky MK; Grau J; Lewis EW
J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
[TBL] [Abstract][Full Text] [Related]
24. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
Li J; Correa AM
Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
[TBL] [Abstract][Full Text] [Related]
25. Phospholipid metabolite 1-palmitoyl-lysophosphatidylcholine enhances human ether-a-go-go-related gene (HERG) K(+) channel function.
Wang J; Wang H; Han H; Zhang Y; Yang B; Nattel S; Wang Z
Circulation; 2001 Nov; 104(22):2645-8. PubMed ID: 11723012
[TBL] [Abstract][Full Text] [Related]
26. The anti-malarial drug halofantrine and its metabolite N-desbutylhalofantrine block HERG potassium channels.
Mbai M; Rajamani S; January CT
Cardiovasc Res; 2002 Sep; 55(4):799-805. PubMed ID: 12176129
[TBL] [Abstract][Full Text] [Related]
27. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.
Kupershmidt S; Yang IC; Hayashi K; Wei J; Chanthaphaychith S; Petersen CI; Johns DC; George AL; Roden DM; Balser JR
FASEB J; 2003 Dec; 17(15):2263-5. PubMed ID: 14525949
[TBL] [Abstract][Full Text] [Related]
28. Effects of fluoroquinolones on HERG currents.
Bischoff U; Schmidt C; Netzer R; Pongs O
Eur J Pharmacol; 2000 Oct; 406(3):341-3. PubMed ID: 11040340
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine.
Ridley JM; Milnes JT; Zhang YH; Witchel HJ; Hancox JC
J Physiol; 2003 Jun; 549(Pt 3):667-72. PubMed ID: 12740430
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
Anesthesiology; 2004 Aug; 101(2):390-8. PubMed ID: 15277922
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
[TBL] [Abstract][Full Text] [Related]
32. A minK-HERG complex regulates the cardiac potassium current I(Kr).
McDonald TV; Yu Z; Ming Z; Palma E; Meyers MB; Wang KW; Goldstein SA; Fishman GI
Nature; 1997 Jul; 388(6639):289-92. PubMed ID: 9230439
[TBL] [Abstract][Full Text] [Related]
33. RNA interference reveals that endogenous Xenopus MinK-related peptides govern mammalian K+ channel function in oocyte expression studies.
Anantharam A; Lewis A; Panaghie G; Gordon E; McCrossan ZA; Lerner DJ; Abbott GW
J Biol Chem; 2003 Apr; 278(14):11739-45. PubMed ID: 12529362
[TBL] [Abstract][Full Text] [Related]
34. Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes.
Friederich P; Solth A
Anesthesiology; 2004 Dec; 101(6):1347-56. PubMed ID: 15564942
[TBL] [Abstract][Full Text] [Related]
35. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Caballero R; Delpón E; Valenzuela C; Longobardo M; González T; Tamargo J
Mol Pharmacol; 2001 Apr; 59(4):825-36. PubMed ID: 11259627
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Paul AA; Witchel HJ; Hancox JC
Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981
[TBL] [Abstract][Full Text] [Related]
37. HERG K(+) channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate.
Bian J; Cui J; McDonald TV
Circ Res; 2001 Dec; 89(12):1168-76. PubMed ID: 11739282
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of bupivacaine on cardiac K channels: role of channel inactivation and subunit composition in drug-channel interaction.
Lipka LJ; Jiang M; Tseng GN
J Cardiovasc Electrophysiol; 1998 Jul; 9(7):727-42. PubMed ID: 9684721
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
Ridley JM; Milnes JT; Benest AV; Masters JD; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2003 Jun; 306(2):388-93. PubMed ID: 12804575
[TBL] [Abstract][Full Text] [Related]
40. Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein.
Thomas D; Zhang W; Wu K; Wimmer AB; Gut B; Wendt-Nordahl G; Kathöfer S; Kreye VA; Katus HA; Schoels W; Kiehn J; Karle CA
Cardiovasc Res; 2003 Jul; 59(1):14-26. PubMed ID: 12829172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
